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Abstract

There is a currently a general trend towards organ-preserving surgery, and urology is no
exception. Specifically, nephron-sparing surgery (NSS) has gained general acceptance for T1a
renal cell carcinoma (guidelines recommendations). Moreover T1b, T2 and even T3 stage tumors
have been included on the nephron sparing list at some centers. An unresolved issue is that of
positive surgical margins (PSM), not only their detection but also the implications for follow up
and treatment. This paper highlights data available on risk factors for PSM, their clinical
relevance, and possible therapeutic consequences.
From the surgeon’s viewpoint, NSS is a daring and risky surgical procedure. Urological
guidelines stress the importance of NSS, and thus the trend is moving in that direction.
Unresolved, however, is the problem of PSM. Trifecta, MIC, and pentafecta are applicable
concepts which attempt to define the optimal endpoint of NSS, but further elaboration is
necessary. Specifically, research needs to focus less on the concept of definitive margins and
more on their identification and avoidance. Although some studies suggest that PSMs do not
influence overall survival rate, the basic idea of preserving tissue that is not cancerous leads to
further medical, social, and psychological considerations.
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Nephron-sparing surgery is considered today by several studies a daring and a risky
surgical procedure, with important (medical, psychological and social) implications

✓

Positive surgical margin needs to be investigated more not as a definition, but for means
of identification/ avoidance that is important for an adequate therapeutic approach.
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Introduction
Over the past 20 years, nephron-sparing surgery
(NSS) has evolved rapidly and is now considered the
standard of care for the treatment of most small renal
masses. In accordance with international guidelines,
NSS is being widely used to treat tumours less than 4
cm. EAU guidelines recommend partial nephrectomy as
the standard procedure for T1a and T1b renal masses in
technically feasible cases (1).
NSS seems to have similar oncological outcomes as
radical nephrectomy. It is also well suited for minimally
invasive surgery either in laparoscopy or using a
robotical approach. Initial indications for NSS relied on
highly selective cases with single surgical kidney or
some tumors with feasible layout for surgery. Due to the
technical evolution and the experience of medical staff
now available in most centers, NSS is indicated for the
T1a stage and may be used within certain limits for other
stages of the disease.
This change in therapeutic approach is based
primarily on findings indicating that organ-sparing
surgery offers the potential for better preservation of
renal function and a lower risk of cardiovascular
sequelae. Oncological outcomes appear to be equivalent
and perioperative morbidity seems to be only minimally
higher
for
nephron-sparing
interventions.
Unfortunately, there are few studies to assess the
significance and impact of the positive surgical margin
(PSM) on the patient's prognosis and what therapeutic
possibilities exist.

Discussion
Research findings related to nephron-sparing
surgery are variable, beginning with case presentations
to studies using small series of patients. For instance,
Lopez-Costea et al. present a group of 137 patients with
NSS, of which 11 had positive surgical margins (2).
Along the same line, Kwon et al., in a study of 770
patients who had open partial nephrectomy, reported a
total of 57 (7%) with PSMs; two of these had a local
recurrence compared with four of 713 who had a
negative margin (0.5%). Patients with a low potential for
malignancy and PSM did not have a local recurrence (3).
Of the factors that might explain cases of local
recurrence having no association with PSMs, the
presence of tumour multifocality is relevant. Although
more frequent for other tumour types, it is associated
with renal cell carcinoma (RCC) and would therefore be
considered as an independent variable related to tumour
recurrence.

Various procedures that could lessen the risk of a
PSM in the final specimen need to be promoted. These
include the use of intraoperative ultrasound (US),
thereby allowing an adequate safety margin, and hilar
clamping that could provide better distinction between
healthy and tumorous tissue as well as aid in the correct
identification of the calyceal system, with the downside
of longer ischaemia time. Regarding this latter point,
Yossepowitch et al. noted that, in their series of NSS,
more PSMs were found in smaller renal masses (4). This
result was probably due to a poor delimitation of healthy
and tumourous tissue, the tendency not to use hilar
clamping, and limiting surgery solely to the tumour.
Concerning renal ischaemia, Yossepovitch et al.
suggested that it might cause involution of cells with
high metabolic activity. Furthermore, others such as
Gallucci et al. proposed selective embolization of large
or hilar tumours (5).
The use of powerful haemostatic systems such as an
argon-beam or ultrasound scalpel, destroying potential
tumour cells in the surgical bed, and the application of
haemostatic materials which could induce direct
ablation of cells through an inflammatory and/or
immunological reaction with cytotoxic capacity all
represent strategies that are available for surgical tumour
extraction.
Alharbi et al. studied the use of intraoperative
ultrasound control of surgical margins during partial
nephrectomy (PN). Their study was conducted from
January, 2010 to December, 2015 on patients with T1T2 renal tumors that had undergone PN performed
through open, laparoscopic or robot-assisted
laparoscopic approaches. Before tumor removal,
ultrasound was performed intraoperatively. The tumor
was removed with the standardized minimal healthy
tissue margin technique. After resection, ultrasound
control of the margins was performed. The removed
tumor was immersed in a saline solution and US was
performed to evaluate in three dimensions whether the
tumor capsule was intact. If the margins were negative,
hemostasis was performed. If not, an extra rim of renal
parenchyma was removed circumferentially to include
the entire remaining margin. In their study, 177 PN were
included, and the results were compared with the
pathology exam. All except one negative US surgical
margins were confirmed. In cases where US
determination was not feasible, the surgical margins
were negative. Overall, all final surgical margins were
negative in the pathology exam even when extra rim
resection of renal parenchyma was required. In
conclusion, intraoperative US had determined the
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margin status with 99% sensitivity and 75% specificity.
Positive and negative predictive values were also 99%
and 75% (6).
A study by Nguyen et al. demonstrated a technique
in which the deep tumor margins were marked by a
needle implanted in situ under US guidance.
Costabel et al. recently reported their 10-year
experience with single kidney patients who had
undergone nephron sparing surgery. Of the 45 patients,
4 were found with positive resection margins, and 4 with
local recurrence (2 of those with positive margins). Of
those 3, they were in T1a and one in T1b. Most
important was that the extemporaneous exam was
negative in all four cases, a thing that does not only
appear in their work (7).
One of the most valuable materials and one of the
few papers dealing with this theme is written by
Steinestel et al. Their review covers a period of 15 years.
The authors identified one of the risk factors for PSM as
the unique kidney condition (either functional or
anatomical). PSM rates of 9 to 28% are described here
(8).
Tumor size is a risk factor about which there is no
definitive agreement yet. Some authors claim that small
tumor masses present higher risk, whereas others state
larger ones present higher risk. Some authors contend
that size is not a risk factor in itself. A second factor
considered by the authors is the tumor topography.
Although no consensus exists, it is generally accepted
that medioreal tumor formations present a higher risk of
PSM.
Reliance on frozen sections, which theoretically
should be useful to the urologist, unfortunately presents
marginal results and generally does not influence the
prognosis of the disease and the rate of detection of the
positive

margins

(9).

Microscopic

examination

performed by an intraoperative surgeon appears to have
better results. More recently, there is a cytology
proposition that delivers results consistent with the final
histopathological exam.
The impact of PSM on local relapse and patient
survival is controversial. Studies claim that PSM is a
predictor of relapse and poor prognosis for the disease.
On the other hand, some authors claim that PSM has no
value in tracking the patient. The general assumption is
that microscopic PSMs do not present a risk factor for
patient survival but that, nevertheless, such situations
should be avoided. Most positions recommend a
conservative rather than aggressive approach toward
surgery.

Wang et al. evaluated the laparoscopic
retroperitoneal approach on 53 patients. The resection
limit was 5 mm and one patient presented PSM but no
relapse at 56 months. Their PSM recommendation
includes surveillance and imaging surveillance (10).
On 63 patients who underwent laparoscopic partial
nephrectomy Osaka et al. found 4 patients (6,3%) with
positive surgical margins. The aim of their study was to
evaluate the predictors of trifecta outcomes for
laparoscopic partial nephrectomy for T1a renal masses
(11).
Joniau et al. studied the outcome of nephronsparing surgery for T1b renal cell carcinoma on a group
of 67 patients (average age – 62) with T1b carcinoma
tumors 4-7 cm. They monitored tumor characteristics,
surgical indication, complications of recurrence, and
time-to-death. Positive margins were diagnosed in 4
patients (6%). None of these patients developed distant
or local metastases within 3 years. Of these patients, 2
ranked Fuhrman III and the other 2 Fuhrman II grades.
None had any surgical indication for reintervention. The
renal ischemia time was 14 minutes on average, using
both the renal pedicle clamping method and
hypothermia (12).
Smith et al. developed a technique for tumor
enucleation for renal cell carcinoma involving the use of
tumor pseudocapsules to remove as little healthy kidney
tissue as possible. Traditionally, the 1 cm margin of the
enucleated tumor was considered optimal, but new
studies have since contradicted this assumption, with
edges under 1 cm being equally safe. Positive margins
were found in about 7% of cases according to other
studies. Analysis of these patients has shown little
influence on the survival rate (13).
The British Association of Urological Surgeons
performed their own set of analyses: their study included
86 UK centers where 1044 partial nephrectomies were
practiced within one year. Testing of the resection
margins was done in 68% of cases, of which only 7%
were positive, and most positive margins were found in
stages T3 - 48%, compared to 6% in T1a. According to
international guidelines for tumor formations below 4
cm, the primary indication is partial nephrectomy with
results as good as radical nephrectomy even with the
presence of positive margin in 6% of the cases (14).
Positive margins were mainly based on tumor size; the
surgical technique chosen did not affect their
appearance. In conclusion, these procedures involved
higher costs (more frequent imaging invasions), as the
oncologists worried about long-term relapse or
metastasis.
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Another studied attempted to follow the evolution
of a larger tumor T3 stage. This study followed the
partial nephrectomy characteristics in renal tumors in
the T3bNxMx stage with limited tumor renal vein
thrombosis. Specifically, 305 patients were studied
between 2004 and 2009, and of these, 2-7% had tumoral
thrombus in the renal vein and became the subject of
their study. All patients had one morpho-functional
kidney, the main reason for partial nephrectomy. On
none of the 7 patients were positive resection margins
found. Only one patient required surgical reintervention
with radical nephrectomy, and he was forced to remain
on dialysis for the remainder of his life. No local
metastasis or local recurrence was detected in any
patient within 30 months after surgery. The approach
used was mainly pararectal. Studies have showed a 5year survival rate of between 47% and 69% (15).
Trifecta is defined as negative surgical margins,
zero perioperative complications, and warm ischaemia
time < 25 minutes. Zargar et al. enhanced this criterion,
adding 90% glomerular rate preservation and no chronic
disease stage upgrading. Other authors coined the term
MIC (negative Margin, Ischaemia no<20 minutes and
no major complications) (16, 17).
Kim et al. found a rate of positive surgical margins
in T1a of 5% versus 6,6% in T1b. The rate of
achievement of Trifecta for T1a and T1b renal mass was
65.3% and 43.3%, respectively (P = 0.017), and the rate
of achievement of Pentafecta was 38.3% and 26.7%,
respectively (P = 0.172). There is large variation in
terms of the rate of achievement for Trifecta, ranging
from 32% to 81%. The overall PSM was 5,8 %, which
is comparable to other studies (18).
Logically the use of partial nephrectomy for higher
risk patients shows superior rates of positive surgical
margins. Maurice et al., in a large retrospective study,
reviewed the outcomes of partial nephrectomy in
patients with more than one adverse pathological
feature, defined as follows: advanced disease pT3,
unfavorable histology (sarcomatoid, collecting duct, or
medullary subtype), high nuclear grade, or any of the
above three criteria. These researchers found a 8,4%
positive surgical margins rate, which increased over
time (19).
However only surgical volume and the robotic
approach seem to be independent predictors for positive
surgical margins after partial nephrectomy (20). Positive
surgical margin is an independent factor of local
recurrence but does not impact survival (21).
Simon et al. performed laparoscopic partial
nephrectomy with selective control of the renal

parenchyma by using a special clamp. Their study
tracked patients who had undergone nephrectomy using
a new type of vascular clamping that allows selective
control of renal parenchyma. The study included
patients with kidney tumors under 4 cm in the T1a and
T1b stages, and Furhman grade 2 or 3. A Nussbaum
special clamp was used, which allowed better control of
renal parenchyma. Three patients aged 60, 64, and 77
years were considered: none had positive margins. In
these, the tumor formation was located peripherally,
which allowed the use of such a clamp. The major
advantage of using this clamp is that ischemia occurs
only at the level of the tumor (22).
Some authors report no or very few PSMs. In a
retrospective comparison study on 102 patients with
open and robotic partial nephrectomy, Omer et al. found
only one case of positive surgical margin (23). This
finding is consistent with the report of Tufek et al. who
on 50 patients with robotic assisted partial nephrectomy
found no positive surgical margins. They used in every
case an intraoperatory ultrasonography with excellent
results. Novel techniques with promising results are also
emerging, such as near-infrared fluorescence after
intravenous injection of indocyanine green (24, 25).
Ricciardulli et al., on 316 patients with laparoscopic and
robotic partial nephrectomy, found positive surgical
margins in 5% and 0% respectively (26).
Volpe et al. studied perioperative and renal
functional outcomes of elective robot-assisted partial
nephrectomy (RAPN) for renal tumors with high
surgical complexity. The purpose of their study was
preoperative and postoperative follow-up on 44 patients
who underwent robotic assisted partial laparoscopic
nephrectomy. Twenty-three patients were in the T1b
stage, the rest in T1a stage. Of these, only 2 were
diagnosed with positive resection margins (4%), below
the median described in the literature. Patients were
followed radiologically for 23 months without local
recurrence or remote metastases. Prior to surgery, all
patients benefited from CT, X-ray, and ultrasonography,
which placed the diagnosis of renal tumor to less than 4
cm, partial laparoscopic nephrectomy being currently
the gold standard for the treatment of this type of tumor.
Uric acid and hemoleucogram levels were monitored
both before and after surgery. The histopathological
examination set the diagnosis of benign tumors in 10
cases. The effectiveness of this type of surgery
compared to classical partial nephrectomy has been
demonstrated, with simple laparoscopic, shortened
operation time, lower blood loss, and faster recovery of
the patient (27).
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Jong et al. compared the surgical margin in open vs
robotic partial nephrectomy. The results were
interesting, given that positive surgical margins were
found in 1,8% of open partial nephrectomies versus
1,3% in robotic partial nephrectomies, that is, surgical
margins were significantly narrower for the robotic
surgery. Of the 2 patients who presented local
recurrence, both had negative surgical margins (28).
For years, a 1cm margin was considered
oncologically safe. But recent studies have
demonstrated that 5 mm margin may also be safe (29).
The authors proposed a 3 mm margin but sufficient data
are not available to support this conclusion (30). On the
other hand, Liu et al., in a study on 118 T1 patients in
three groups—open radical nephrectomy, open partial
nephrectomy and laparoscopic partial nephrectomy
(31)—found that positive surgical margins were
significantly lower in the open partial nephrectomy than
in laparoscopic partial nephrectomy.

Intraoperatory ultrasound is the only method which
is used sufficiently to ascertain an impact on outcomes.
Although cytology shows promising results, it is
typically limited by staff experience. The use of
indocyanine green is promising though still not
widespred.
Even more intriguing is the differential diagnosis of
this pathology with retroperitoneal space pathology (44,
45). Positive surgical margin needs to be investigated
more not as a definition, but for means of identification/
avoidance that is important for an adequate therapeutic
approach.
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